REFERENCES
1. Ball, J. R., and Kiloh, L. G. (1959): A controlled trial of imipramine in treatment of depressive states. Br. Med. J., 2:52. 2. Carney, M. W. P., Roth, M., and Garside, R. F. (1965): The diagnosis of depressive syndromes and the prediction of ЕСТ response. Br. J. Psychiatry, 121:35. 3. Covi, L., Lipman, R. S., Derogatis, R., Smith, J. E., and Pattison, J. H. (1974): Drugs and group psychotherapy in neurotic depression. Am. J. Psychiatry, 131:191. 4. Davidson, J., Pelton, S., Krishnan, R. R., and Allf, B. (1986): The Newcastle anxiety depression index in relationship to the effects of MAOI and TCA drugs. J. Affective Disord., 11:51-58. 5. Friedman, A. S. (1975): Interaction of drug therapy with marital therapy in depressive patients. Arch. Gen. Psychiatry, 32:619. 6. Hamilton, M., and White, J. M. (1959): Clinical syndromes in depressive states. J. Merit. Sci., 105:985-998. 7. Hollister, L. E., Overall, J. E., Johnson, M. H., Shelton, J., KJmbell, I., and Brunse, A. (1966): Amitriptyline alone and combined with perphenazine in newly admitted depressed patients. /. Nerv. Ment. Dis., 142:460-469. 8. Hollister, L. E., Overall, J. E., Shelton, J., Pennington, V., Kimbell, I., and Johnson, M. (1967): Drug therapy of depression: Amitriptyline, perphenazine and their combination in different syndromes. Arch. Gen. Psychiatry, 17:486-493. 9. Johnstone, E. C, Cunningham Owens, D. G., Frith, C. D., McPherson, K., Dowie, C, Riley, G., and Gold, A. (1980): Neurotic illness and its response to anxiolytic and antidepressant treatment. Psychol. Med., 10:321-328. 10. Kahn, R. J., McNair, D. M., Lipman, R. S., Covi, L., Rickels, K., Downing, R., Fisher, S., and Frankenthaler, L. M. (1986): Imipramine and chlordiazepoxide in depressive and anxiety disorders. Arch. Gen. Psychiatry, 43:79-85. 11. Kendell, R. E. (1968): The Classification of Depressive Illnesses. Maudsley Monogr. No. 18. Oxford University Press, London. 12. Kiloh, L. G, Andrews, G, Neilson, M., and Bianchi, G. N. (1972): The relationship of the syndromes called endogenous and neurotic depression. Br. J. Psychiatry, 121:183-196. 13. Kiloh, L. G, and Garside, E. F. (1963): The independence of neurotic depression and endogenous depression. Br. J. Psychiatry, 109:451-463. 14. Kuhn, R. (1958): The treatment of depressive states with G22355 (imipramine hydrochloride). Am. J. Psychiatry, 115:459. 15. Liebowitz, M. R., Quitkin, M., Stewart, J. W., McGrath, P. J., Harrison, W., Rabkin, J., Tricamo, E., Markowitz, J. S., and Klein, D. F. (1984): Phenelzine v imipramine in atypical depression. Arch. Gen. Psychiatry, 41:669-677. 16. Marks, I. (1983): Are there anticompulsive or antiphobic drugs? Review of the evidence. Br. J. Psychiatry, 143:338-347. 17. Overall, J. E., Hollister, L. E., Johnson, M., and Pennington, V. (1966): Nosology of depression and differential response to drugs. J. Am. Med. Assoc, 195:946-948. 18. Paykel, E. S. (1971): Classification of depressed patients: A cluster analysis derived grouping. Br. J. Psychiatry, 118:275-288. 19. Paykel, E. S. (1972): Depressive typologies and response to amitriptyline. Br. J. Psychiatry, 120: 147-156. 20. Paykel, E. S. (1979): Predictors of treatment response. In: Psychopharmacology of Affective Disorders, edited by E. S. Paykel and A. Coppen, pp. 193-220. Oxford University Press, Oxford. 21. Paykel, E. S. (1985): The clinical interview for depression development, reliability and validity. J. Affective Disord., 9:85-96. 22. Paykel, E. S., Parker, R. R., Rowan, P. R., Rao, B. M, and Taylor, С N. (1983): Nosology of atypical depression. Psychol. Med., 13:131-139. 23. Paykel, E. S., Prusoff, B. A., and Klerman, G. L. (1971): The endogenous-neurotic continuum in depression: Rater independence and factor distributions. / Psychiatr. Res., 8:73-90. 24. Paykel, E. S., Rowan, P. R., Parker, R. R., and Bhat, A. V. (1982): Response to phenelzine and amitriptyline in sub-types of neurotic depression. Arch. Gen. Psychiatry, 39:1041-1049. 25. Pollitt, J. (1965): Depression and Its Treatment. Heinemann, London. 26. Prusoff, B. A., and Paykel, E. S. (1977): Typological prediction of responses to amitriptyline: A replication study. Int. Pharmacopsychiat., 12:153-159. 27. Rao, V. A., and Coppen, A. (1978): Classification of depression and response to amitriptyline therapy. Psychol. Med., 9:321-325. 28. Ravaris, С L., Robinson, D. S., Ives, J. O, Nies, A., and Bartlett, D. (1980): Phenelzine and amitriptyline in the treatment of depression. Arch. Gen. Psychiatry, 37:1075-1080. 29. Robinson, D. S., Nies, A., Ravaris, С L., Ives, J. O, and Lamborn, K. R. (1974): Treatment response to MAO inhibitors: Relation to depressive typology and blood platelet MAO inhibition. In: Classification and Prediction of Outcome of Depression, pp. 259-267. Schattauer-Verlag, Stuttgart. 30. Rosenthal, S. H., and Gudeman, J. E. (1967): The endogenous depressive pattern: An empirical investigation. Arch. Gen. Psychiatry, 16:241-249. 31. Rosenthal, S. H., and Gudeman, J. E. (1967): The self-pitying constellation in depression. Br. J. Psychiatry, 113:485-489. 32. Rosenthal, S. H., and Klerman, G L. (1966): Content and consistency in the endogenous depressive pattern. Br. J. Psychiatry, 112:471-484. 33. Rowan, P. R., Paykel, E. S., and Parker, R. R. (1982): Phenelzine and amitriptyline: Effects on symptoms of neurotic depression. Br. J. Psychiatry, 140:475-483. 34. Sheehan, D. V., Ballenger, J., and Jacobsen, G. (1980): Treatment of endogenous anxiety with phobic hysterical and hypochondriacal symptoms. Arch. Gen. Psychiatry, 37:51-59. 35. Sireling, L. I., Freeling, P., Paykel, E. S., and Rao, В . М . (1985): Depression in general practice: Clinical features and comparison with out-patients. Br. J. Psychiatry, 147:119-126. 36. Sireling, L. I., Paykel, E. S., Freeling, P., Rao, В . М ., and Patel, S. P. (1985): Depression in general practice: Case thresholds and diagnosis. Br. J. Psychiatry, 147:113-119. 37. Tyrer, P. (1976): Towards rational therapy with monoamine oxidase inhibitors. Br. J. Psychiatry, 128:354-360. 38. Uhlenuhuth, E. H., and Park, L. С (1964): The influence of medication (imipramine) and doctor in relieving depressed psychoneurotic patients. J. Psychiatr. Res., 2:101. 39. West, E. D., and Dally, P. J. (1959): Effects of iproniazid in depressive syndromes. Br. Med. J., 1:1491-1499. 40. Wittenborn, J. R., Plante, M., Burgess, F., and Maurer, H. (1962): A comparison of imipramine, ЕСТ and placebo in the treatment of depression. J. Nerv. Ment. Dis., 135:131-137. 41. Zitrin, С M., Klein, D. F., and Woerner, M. G. (1980): Treatment of agoraphobia with group exposure in vivo and imipramine. Arch. Gen. Psychiatry, 37:63-72.
Anxious Depression: Assessment and Treatment, edited by G. Racagni and
E. Smeraldi. Raven Press, New York © 1987.